OraVital - professional treatment for gum disease, bad breath, halitosis, gingivitis, periodontitis


OraVital® Antibiotic and Antimicrobial Rinses and Creams

Periodontal disease can be challenging to treat because pathogens are protected within an oral biofilm that is difficult for antimicrobials to penetrate. Mechanical removal of biofilm is typically only partially effective because biofilms can rapidly reorganize. Thus using an antibacterial rinse as an adjunct to mechanical removal of plaque and calculus is a significantly more effective way of dealing with oral biofilm infections.

Antimicrobial rinses are most often used to complement mechanical therapy to aid in controlling plaque buildup. Antibiotic rinses include low-dose antibiotics in colloidal suspensions - these rinses can impact pathogens up to 4,000 times more effectively than systemic antibiotics, with immediate treatment onset and without systemic implications. Since infected gum tissue is typically swollen and may have pockets around the teeth, medicated rinses are able to enter the sulcus and are drawn into the depth of these pockets by a reduction in crevicular fluid pressure (the Venturi Effect). Particles dissolve over several hours.

OraVital® Antibiotic Rinses

OraVital® antibiotic rinses used three times a day for a two-week period are highly effective in reducing bacteria that cause periodontal disease, chronic halitosis and other oral infections.

Prepared by OraVital® designated compounding pharmacies, these rinses are available to OraVital® Certified clinics in several formulations. They are customized according to a patient's specific oral condition, including number of bleeding points, number of pockets, depth of pockets, presence of bone loss, and/or a microbiology assessment.

Antibiotic rinses eliminate periodontal pathogens, yeasts and parasites and rebalance the oral biofilm to healthy levels. They also reduce periodontal pockets by 84%* and bleeding points by 87%* (*clinical average). Proper oral care follow up will generally control or prevent the return of disease.

OraVital® Antibiotic Creams

For the treatment of implantitis, denture stomatitis, deep pockets and interproximal odours, OraVital® antibiotic-antifungal cream is highly effective. This cream can be applied by the patient at home to localized areas of inflammation or bleeding for a two-week period until gums heal.

OraVital® Antimicrobial Rinses

The OraVital® System includes the use of maintenance rinses that are formulated to provide an effective adjunct for your patients' home and office oral care.

SmartMouth™: This is an effective treatment for many patients with [mild to moderate] halitosis. SmartMouth includes two solutions - one with sodium chlorite and another with zinc chloride. Prior to rinsing, the patient pumps equal amounts of each solution into a rinse cup. They combine to form a zinc++ ion that seals protein receptors on periodontal pathogens, inducing starvation and therefore helping to maintain healthy oral tissues. As well, since zinc ions block the ability of bacteria to ingest protein particles, this prevents the formation of volatile sulphur compounds (VSCs) that cause halitosis. SmartMouth toothpaste, mints and gum contribute to zinc ion effectiveness.

OraVital® CDLx is a sodium chlorite rinse that destroys the enzymes required by periodontal pathogens for protein breakdown. It also acts as a neutralizing agent for odours these bacteria produce. As well, Xylitol, a plant-derived sweetening agent, is effective in decreasing Streptococci mutans and is a preventive agent for tooth decay. This rinse is available in two formulations: mint flavour or flavour-and-colour-free.

OraVital® CPCx contains cetylpyridinium chloride, which has a bactericidal action similar to chlorhexidine. This rinse is effective in decreasing both periodontal pathogens and the Streptococci that initiate caries. It is also an effective preprocedural rinse. The addition of Xylitol reinforces the reduction in caries-producing bacteria.

"Because periodontitis in the general population is under-diagnosed and undertreated, what measures can improve its detections and management in persons at increased risk for CVD events?"

Vincent E. Friedewald, MD, Kenneth S. Kornman, DDS, PhD, James D. Beck, PhD, Robert Genco, DDS, PhD, Allison Goldfine, MD, Peter Libby, MD, Steven Offenbacher, DDS, PhD, MMsc, Paul M. Ridker, MD, MPH, Thomas E. Van Dyke, DDS, PhD, and William C. Roberts, MD. Periodontitis and Atherosclertic Cardiovascular Disease. American Journal of Cardiology 2009: 104:59-68.

Our success speaks for itself. OraVital® assessment and treatment methods can control gingivitis and mild to moderate periodontitis.


Contact OraVital

toll free